Fujimoto Chemicals

Osaka, Japan
Hybrid — also manufactures internal programs
Small Molecule API High-Potency APIs Oligonucleotide
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (1)

Quick Facts: Fujimoto Chemicals

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Osaka, Japan
Website
Modalities
Small Molecule API, High-Potency APIs, Oligonucleotide
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Fujimoto Chemicals

Fujimoto Chemicals makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, High-Potency APIs, Oligonucleotide. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.fujimoto-chem.co.jp/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Fujimoto Chemicals FDA Inspection History

2023-05
NAI VAI OAI
Date Site Type Observations Classification
2023-05-12
Fujimoto Chemicals Co., Ltd.
Izumiotsu Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Fujimoto Chemicals

How many FDA inspections does Fujimoto Chemicals have on record?
CDMO Signal tracks 1 FDA inspection for Fujimoto Chemicals, sourced from the FDA inspection database. See the full inspection history above.
Has Fujimoto Chemicals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Fujimoto Chemicals.
Does Fujimoto Chemicals have a CDMO Signal Score?
Not yet. Fujimoto Chemicals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Fujimoto Chemicals for a manufacturing program?
Use the free AI matchmaker to compare Fujimoto Chemicals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs →

Similar CDMOs

Juzen Chemical
Toyama, Japan
Small Molecule API, Intermediates, High-Potency APIs, Oligonucleotide
ChemExpress
Shanghai, China
Small Molecule API, Intermediates, High-Potency APIs, ADC / Bioconjugation, Peptides, Oligonucleotide
Kolon Life Science
Gwacheon, South Korea
Small Molecule API, Intermediates, Oligonucleotide, High-Potency APIs
Sichuan Qingmu Pharmaceutical
Meishan, Sichuan, China
Small Molecule API, High-Potency APIs, Cytotoxics, Oligonucleotide
Anax Laboratories
Hyderabad, Telangana, India
Small Molecule API, High-Potency APIs, Peptides, Oligonucleotide, ADC / Bioconjugation, Custom Synthesis

Compare Fujimoto Chemicals with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Fujimoto Chemicals
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.